We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTNT
11551
DELISTED
Quotient Limited Ordinary Shares
QTNT
$75K ﹤0.01%
7,823
+6,621
+551% +$141K
TGA
11552
DELISTED
Transglobe Energy Corp
TGA
$75K ﹤0.01%
+22,249
New +$95.2K
KCGI.WS
11553
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
$75K ﹤0.01%
375,460
-134,735
-26% -$52.3K
ANIX icon
11554
Anixa Biosciences
ANIX
$108M
$74K ﹤0.01%
+24,294
New +$76.6K
APYX icon
11555
CALL
Apyx Medical
APYX
$128M
$74K ﹤0.01%
+12,700
New +$65.2K
FTFT icon
11556
CALL
Future FinTech Group
FTFT
$1.72M
$74K ﹤0.01%
219
+140
+177% +$62.2K
MNOV icon
11557
MediciNova
MNOV
$64.5M
$74K ﹤0.01%
+29,133
New +$76K
SGLY icon
11558
PUT
Singularity Future Technology
SGLY
$4.41M
$74K ﹤0.01%
+174
New +$142K
AXLA
11559
CALL
DELISTED
Axcella Health Inc. Common Stock
AXLA
$74K ﹤0.01%
1,464
-3,852
-72% -$190K
MSDAW
11560
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$74K ﹤0.01%
200,000
-101,050
-34% -$50.6K
SREV
11561
CALL
DELISTED
ServiceSource International, Inc.
SREV
$74K ﹤0.01%
50,400
-3,300
-6% -$4.39K
NTP
11562
DELISTED
Nam Tai Property Inc.
NTP
$74K ﹤0.01%
17,574
-58,985
-77% -$348K
AGMH icon
11563
AGM Group Holdings
AGMH
$4.73M
$73K ﹤0.01%
+1,164
New +$113K
ARQQ icon
11564
Arqit Quantum
ARQQ
$424M
$73K ﹤0.01%
459
-1,623
-78% -$336K
BDSX icon
11565
PUT
Biodesix
BDSX
$253M
$73K ﹤0.01%
+2,215
New +$72K
BTCT icon
11566
BTC Digital
BTCT
$7.56M
$73K ﹤0.01%
2,615
+1,487
+132% +$70.2K
BVN icon
11567
CALL
Compañía de Minas Buenaventura
BVN
$8.57B
$73K ﹤0.01%
11,000
-30,300
-73% -$262K
DAO
11568
PUT
Youdao
DAO
$2.17B
$73K ﹤0.01%
+14,900
New +$88.9K
ETON icon
11569
Eton Pharmaceutcials
ETON
$1.68B
$73K ﹤0.01%
+27,775
New +$93.2K
EVAX
11570
PUT
Evaxion A/S
EVAX
$27.9M
$73K ﹤0.01%
746
+496
+198% +$56.7K
GNPX icon
11571
CALL
Genprex
GNPX
$2.18M
$73K ﹤0.01%
1
LODE icon
11572
CALL
Comstock
LODE
$263M
$73K ﹤0.01%
11,720
-290
-2% -$2.89K
RAIL icon
11573
CALL
FreightCar America
RAIL
$240M
$73K ﹤0.01%
20,000
-21,600
-52% -$103K
RES icon
11574
CALL
RPC Inc
RES
$1.41B
$73K ﹤0.01%
10,500
-6,800
-39% -$64.9K
TALK icon
11575
CALL
Talkspace
TALK
$871M
$73K ﹤0.01%
43,000
-10,100
-19% -$15.2K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.